CC
CRDF icon

Callan Capital’s Cardiff Oncology CRDF Stock Holding History

Callan Capital’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$319K Hold
101,575
– – 0.02% 269
2024
Q4 		$441K Buy
101,575
+10,108
+11% +$31.6K 0.03% 198
2024
Q3 		$244K Buy
91,467
+26,420
+41% +$62.4K 0.02% 297
2024
Q2 		$144K Buy
65,047
+22,300
+52% +$84K 0.01% 303
2024
Q1 		$228K Buy
42,747
+11,600
+37% +$30.8K 0.02% 255
2023
Q4 		$46.1K Hold
31,147
– – ﹤0.01% 232
2023
Q3 		$43.3K Buy
31,147
+17,560
+129% +$29.6K ﹤0.01% 199
2023
Q2 		$20K Hold
13,587
– – ﹤0.01% 182
2023
Q1 		$22.4K Hold
13,587
– – ﹤0.01% 181
2022
Q4 		$19K Buy
+13,587
New +$19.5K ﹤0.01% 184
2015
Q3 		– Sell
-157
Closed -$115K – 64
2015
Q2 		$115K Buy
+157
New +$111K 0.02% 66

Other funds holding CRDF

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return